Product category:
Cell/tissue handling and counting
News Release from: Chip-Man Technologies
Edited by the Laboratorytalk Editorial
Team on 16 November 2006
Kolb drives Chip-Man expansion into US
market
Following success in Europe, Chip-Man Technologies reports that Al Kolb, KeyTech Solutions, has been contracted as a consultant to assist in the introduction of the Cell-IQ to the United States
Al Kolb, a well known and successful consultant on early drug discovery technologies, believes that Chip-Man and their Cell-IQ system will be very successful in the USA He said: "I have the opportunity to look at many companies and to evaluate new technologies
This article was originally published on Laboratorytalk on 20 Mar 2003 at 8.00am (UK)
Related stories
Double anniversary at Focus
Supplier of one quarter of the world's haematology analysers celebrates its twentieth birthday, while its parent company celebrates its fiftieth
Merger of HTP operations
"With a combined instrumentation and biochemistry team we can respond faster and more flexibly to the assaying demands of current and future customers"
"In my experience, Chip-Man and Cell-IQ both stand out.
He continued, "The management team of Chip-Man are knowledgeable and experienced with a good understanding of the market and their customers.
"The Cell-IQ is an excellent and unique product that meets a real market need.
"We are looking forward to a successful launch of Cell-IQ in the USA and establishing Chip-Man as a premier cell imaging and analysis company".
Dr Kolb operates his own consulting company, KeyTech Solutions, which focuses on the identification, development and commercialisation of drug discovery technologies.
He is one of the founders of the Society for Biomolecular Sciences and currently serves as its president.
He has worked for industry leaders such as Beckman and Packard (now PerkinElmer), and some of his projects have included the development of micro-plates and readers, assay technologies, as well as large scale automation systems.
He also serves as a scientific advisor to corporations, in addition to working with universities and a variety of companies in the evaluation of drug discovery technologies".
"Al is an excellent addition to our team" Chip-Man Technologies's chief executive officer Juha Korpinen explained.
"His wealth of knowledge and understanding of the life science industry will help drive the Cell-IQ into the US market".
Cell-IQ represents a major breakthrough in cell analysis by enabling real time monitoring of all morphological and physiological changes in cell lines, primary cells, co-cultures and monolayer tissue models.
The Cell-IQ software 'learns' to recognise and record cellular change and to output these results as real time moving images and simple multi-parameter graphics.
• Chip-Man Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
